Search Results

Business

ViaDerma Provides Highlights of Quarterly Financial Report

ViaDerma, Inc. is pleased to announce that on May 13, 2024, the Company released its quarterly report for the period ending March 31, 2024.

June 6, 2024

·

2 min read

Press Releases

ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth

October 4, 2024

·

2 min read

Press Releases

ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires

August 1, 2024

·

2 min read

Biotech Beach

ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More

ViaDerma, Inc. is pleased to announce several new and exciting business updates for current and prospective shareholders, customers, partners, and healthcare providers.

October 24, 2023

·

4 min read

Policy

ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More

ViaDerma, Inc. is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and healthcare providers.

July 6, 2023

·

3 min read

Biotech Beach

ViaDerma Provides an Update on Current & Future Business Activities

ViaDerma, Inc. is pleased to provide an update on current business activities.

March 2, 2023

·

2 min read

Biotech Beach

ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products

ViaDerma, Inc., announces the successful completion of its internal quality control testing for their new Vitastem products.

September 15, 2022

·

2 min read

Biotech Beach

ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products

ViaDerma, Inc., announces plans to conduct additional internal quality control testing for their new Vitastem products.

June 22, 2022

·

2 min read

Biotech Beach

ViaDerma, Inc. Provides Updates on Current Business Activities

About ViaDerma, Inc. ViaDerma, Inc. is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas.

June 24, 2021

·

1 min read

Business

ViaDerma’s 2021 Annual Report Shows Strong Revenue Growth Over the Previous YearRevenues increased by over 4000% in 2021, while liabilities decreased by more than 25%

ViaDerma, Inc., announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with $514,007 in revenue, compared to only $11,468 the previous year.

March 31, 2022

·

1 min read